A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy - PubMed (original) (raw)
Case Reports
doi: 10.3851/IMP1953. Epub 2011 Nov 4.
Affiliations
- PMID: 22293514
- DOI: 10.3851/IMP1953
Case Reports
A case of a potential drug interaction between clobazam and etravirine-based antiretroviral therapy
Mark Naccarato et al. Antivir Ther. 2012.
Abstract
The cytochrome P450 isoforms primarily involved in clobazam metabolism are CYP3A4 and 2C19. Drugs that modulate these enzymes would then be expected to alter the exposure of clobazam and its major metabolites. Etravirine, a second-generation non-nucleoside reverse transcriptase inhibitor has been shown to induce CYP3A4, while inhibiting CYP2C9 and CYP2C19. We report a case in which a potential drug interaction between clobazam and etravirine may have led to increased concentrations of clobazam and its pharmacologically active metabolite, N-desmethylclobazam, causing neurotoxic symptoms.
Similar articles
- Clinical perspective on antiretroviral drug-drug interactions with the non-nucleoside reverse transcriptase inhibitor etravirine.
Kakuda TN, Schöller-Gyüre M, Hoetelmans RM. Kakuda TN, et al. Antivir Ther. 2010;15(6):817-29. doi: 10.3851/IMP1652. Antivir Ther. 2010. PMID: 20834094 Review. - [Etravirine drug interactions].
Pérez VE, Sánchez-Parra C, Serrano Villar S. Pérez VE, et al. Enferm Infecc Microbiol Clin. 2009 Dec;27 Suppl 2:27-31. doi: 10.1016/S0213-005X(09)73216-1. Enferm Infecc Microbiol Clin. 2009. PMID: 20116625 Review. Spanish. - Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.
Walzer M, Bekersky I, Blum RA, Tolbert D. Walzer M, et al. Pharmacotherapy. 2012 Apr;32(4):340-53. doi: 10.1002/j.1875-9114.2012.01028.x. Epub 2012 Mar 15. Pharmacotherapy. 2012. PMID: 22422635 Clinical Trial. - [Introduction. Etravirine: a new standard of potency and safety among non-nucleoside analogues].
Domingo P. Domingo P. Enferm Infecc Microbiol Clin. 2009 Dec;27 Suppl 2:1. doi: 10.1016/S0213-005X(09)73211-2. Epub 2010 Jan 25. Enferm Infecc Microbiol Clin. 2009. PMID: 20116620 Spanish. No abstract available. - Etravirine: new drug. Multidrug-resistant HIV: another option.
[No authors listed] [No authors listed] Prescrire Int. 2009 Jun;18(101):102-3. Prescrire Int. 2009. PMID: 19637414
Cited by
- Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review.
Balachandran P, Elsohly M, Hill KP. Balachandran P, et al. J Gen Intern Med. 2021 Jul;36(7):2074-2084. doi: 10.1007/s11606-020-06504-8. Epub 2021 Jan 29. J Gen Intern Med. 2021. PMID: 33515191 Free PMC article. Review. - Persistent Hypersomnolence Following Clobazam in a Child With Epilepsy and Undiagnosed CYP2C19 Polymorphism.
Hamilton KE, Shelton CM, Wheless J, Phelps SJ. Hamilton KE, et al. J Pediatr Pharmacol Ther. 2020;25(4):320-327. doi: 10.5863/1551-6776-25.4.320. J Pediatr Pharmacol Ther. 2020. PMID: 32461746 Free PMC article. - Hypothermia in an Adolescent Due to Probable Drug-Drug Interaction Involving Clobazam.
Parman MG, Holmes AP. Parman MG, et al. J Pediatr Pharmacol Ther. 2019 Mar-Apr;24(2):156-159. doi: 10.5863/1551-6776-24.2.156. J Pediatr Pharmacol Ther. 2019. PMID: 31019409 Free PMC article. - PharmGKB summary: clobazam pathway, pharmacokinetics.
Huddart R, Leeder JS, Altman RB, Klein TE. Huddart R, et al. Pharmacogenet Genomics. 2018 Apr;28(4):110-115. doi: 10.1097/FPC.0000000000000327. Pharmacogenet Genomics. 2018. PMID: 29517622 Free PMC article. No abstract available. - The Pharmacology and Toxicology of Third-Generation Anticonvulsant Drugs.
LaPenna P, Tormoehlen LM. LaPenna P, et al. J Med Toxicol. 2017 Dec;13(4):329-342. doi: 10.1007/s13181-017-0626-4. Epub 2017 Aug 16. J Med Toxicol. 2017. PMID: 28815428 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical